Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel | European Heart Journal | 2020 | 301 |
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action | JAMA Cardiology | 2020 | 85 |
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia | Journal of the American College of Cardiology | 2020 | 65 |
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM | Clinical Chemistry and Laboratory Medicine | 2020 | 50 |
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM | Atherosclerosis | 2020 | 49 |
Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities | Journal of Internal Medicine | 2020 | 44 |
Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk | Journal of Internal Medicine | 2020 | 36 |
Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study | British Journal of Anaesthesia | 2020 | 35 |
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone | Metabolism: Clinical and Experimental | 2020 | 27 |
High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies | PLoS Biology | 2020 | 24 |
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a) | Metabolism: Clinical and Experimental | 2020 | 23 |
Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease | Journal of the American Heart Association | 2020 | 16 |
Assessing the evidence-practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics | European Journal of Heart Failure | 2020 | 15 |
Quantifying dietary vitamin K and its link to cardiovascular health: a narrative review | Food and Function | 2020 | 14 |
Is breast arterial calcification associated with coronary artery disease?-A systematic review and meta-analysis | PLoS ONE | 2020 | 13 |
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a) | Journal of Clinical Lipidology | 2020 | 12 |
Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application | Heart Lung and Circulation | 2020 | 11 |
A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma | Lung Cancer | 2020 | 10 |
The brave new world of genetic testing in the management of the dyslipidaemias | Current Opinion in Cardiology | 2020 | 7 |
Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia | Clinica Chimica Acta | 2020 | 7 |
The Schlager mouse as a model of altered retinal phenotype | Neural Regeneration Research | 2020 | 6 |
Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes? | Clinical Genetics | 2020 | 6 |
Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software | Journal of Nuclear Cardiology | 2020 | 6 |
An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia | Atherosclerosis | 2020 | 5 |
Acute rupture of a sinus of Valsalva aneurysm into the right atrium: a case report and a narrative review | BMC Cardiovascular Disorders | 2020 | 4 |